Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02959840 · ClinicalTrials.gov registry record · Phase 4
Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean
A Phase 4 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
NCT02959840: Completed Phase 4 study, sponsored by Rutgers, The State University of New Jersey.
NCT02959840 is a Phase 4 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 180 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02959840, a Phase 4 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of acupressure point P6 stimulation versus intravenous ondansetron plus metoclopramide versus no antiemetic prophylaxis during elective cesarean section under regional anesthesia.
Primary Outcome
The investigators will analyze if there is a statistically significant difference between the number of patients that experience nausea at any point during the surgical procedure in each group.
Interventions
- DRUG Ondansetron
- DRUG Metoclopramide
- DEVICE Acupressure Point P6 stimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-08-23 |
| Phase | Phase 4 |
What the finished NCT02959840 record still lists
NCT02959840 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 3 interventions - of which Ondansetron is the first listed.
NCT02959840 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02959840 about?
NCT02959840 is a clinical study titled "Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean". The purpose of this study is to compare the effectiveness of acupressure point P6 stimulation versus intravenous ondansetron plus metoclopramide versus no antiemetic prophylaxis during elective cesarean section under regional anesthesia.
What is the current status of trial NCT02959840?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2015-07. Estimated completion is 2017-08-23.
What interventions are being tested in trial NCT02959840?
The interventions under investigation include: Ondansetron (DRUG), Metoclopramide (DRUG), Acupressure Point P6 stimulator (DEVICE).
Who is sponsoring clinical trial NCT02959840?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02959840's enrollment target sits among peer trials
180 466th of 2000 higher than 1,525 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia